Richard Radcliffe
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 27 | 2020 | 629 | 3.590 |
Why?
| | Quantitative Trait Loci | 10 | 2020 | 388 | 2.430 |
Why?
| | Drug Tolerance | 10 | 2020 | 99 | 2.270 |
Why?
| | Alcohol Drinking | 8 | 2017 | 847 | 1.440 |
Why?
| | Alcoholism | 15 | 2020 | 830 | 1.430 |
Why?
| | Chromosome Mapping | 18 | 2020 | 505 | 1.300 |
Why?
| | Mice, Inbred Strains | 24 | 2020 | 384 | 1.090 |
Why?
| | Reflex, Righting | 4 | 2018 | 15 | 1.060 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 2 | 2016 | 55 | 0.860 |
Why?
| | Receptors, Neurotensin | 7 | 2006 | 11 | 0.790 |
Why?
| | Motor Activity | 11 | 2010 | 701 | 0.790 |
Why?
| | Quantitative Trait, Heritable | 9 | 2017 | 118 | 0.750 |
Why?
| | Central Nervous System Depressants | 8 | 2011 | 83 | 0.670 |
Why?
| | Sleep | 6 | 2016 | 896 | 0.640 |
Why?
| | Methamphetamine | 2 | 2011 | 75 | 0.620 |
Why?
| | Mice | 52 | 2020 | 18266 | 0.600 |
Why?
| | Locomotion | 3 | 2016 | 102 | 0.570 |
Why?
| | Behavior, Animal | 8 | 2017 | 530 | 0.560 |
Why?
| | Genotype | 14 | 2020 | 1866 | 0.560 |
Why?
| | Fear | 7 | 2011 | 371 | 0.550 |
Why?
| | Animals | 63 | 2020 | 38030 | 0.530 |
Why?
| | Consummatory Behavior | 1 | 2017 | 3 | 0.520 |
Why?
| | Species Specificity | 9 | 2017 | 542 | 0.450 |
Why?
| | Rats, Inbred Strains | 6 | 2007 | 316 | 0.440 |
Why?
| | Mice, Inbred DBA | 11 | 2011 | 185 | 0.430 |
Why?
| | Genome | 1 | 2016 | 307 | 0.410 |
Why?
| | Darkness | 1 | 2013 | 26 | 0.390 |
Why?
| | Migraine with Aura | 1 | 2013 | 6 | 0.390 |
Why?
| | Gene Expression Profiling | 5 | 2017 | 1790 | 0.380 |
Why?
| | Crosses, Genetic | 5 | 2007 | 120 | 0.380 |
Why?
| | Neurotensin | 6 | 2001 | 14 | 0.370 |
Why?
| | Brain Chemistry | 6 | 2009 | 121 | 0.360 |
Why?
| | Conditioning, Classical | 4 | 2003 | 120 | 0.360 |
Why?
| | Genetic Predisposition to Disease | 7 | 2018 | 2455 | 0.360 |
Why?
| | Phenotype | 12 | 2017 | 3186 | 0.360 |
Why?
| | Rats | 12 | 2017 | 5574 | 0.340 |
Why?
| | Dopamine Agents | 1 | 2011 | 22 | 0.340 |
Why?
| | Basal Ganglia | 1 | 2011 | 60 | 0.330 |
Why?
| | Genetic Markers | 5 | 2009 | 337 | 0.330 |
Why?
| | Mice, Inbred C57BL | 19 | 2018 | 6021 | 0.330 |
Why?
| | Amphetamine-Related Disorders | 1 | 2011 | 53 | 0.320 |
Why?
| | Recombination, Genetic | 3 | 1998 | 202 | 0.310 |
Why?
| | Hypnotics and Sedatives | 3 | 2018 | 221 | 0.300 |
Why?
| | Central Nervous System Stimulants | 1 | 2011 | 183 | 0.290 |
Why?
| | Breeding | 2 | 2006 | 64 | 0.290 |
Why?
| | Alcohol-Induced Disorders, Nervous System | 1 | 2009 | 7 | 0.290 |
Why?
| | Brain | 10 | 2020 | 2981 | 0.290 |
Why?
| | Mice, 129 Strain | 3 | 2016 | 83 | 0.290 |
Why?
| | Reflex | 5 | 2007 | 69 | 0.280 |
Why?
| | Dopamine | 1 | 2011 | 295 | 0.280 |
Why?
| | High-Throughput Nucleotide Sequencing | 3 | 2018 | 538 | 0.280 |
Why?
| | Disease Models, Animal | 4 | 2018 | 4565 | 0.270 |
Why?
| | Alcohol-Related Disorders | 1 | 2009 | 125 | 0.260 |
Why?
| | Dose-Response Relationship, Drug | 11 | 2016 | 2018 | 0.260 |
Why?
| | MicroRNAs | 4 | 2018 | 695 | 0.260 |
Why?
| | Male | 38 | 2020 | 73014 | 0.260 |
Why?
| | Transcriptome | 2 | 2017 | 1066 | 0.250 |
Why?
| | Models, Animal | 2 | 2010 | 386 | 0.250 |
Why?
| | Databases, Genetic | 2 | 2017 | 239 | 0.250 |
Why?
| | Sequence Analysis, RNA | 3 | 2018 | 441 | 0.220 |
Why?
| | Selection, Genetic | 3 | 2007 | 269 | 0.220 |
Why?
| | Haplotypes | 2 | 2006 | 505 | 0.220 |
Why?
| | Behavioral Sciences | 1 | 2004 | 8 | 0.210 |
Why?
| | Neurosciences | 1 | 2004 | 21 | 0.210 |
Why?
| | Animals, Laboratory | 1 | 2004 | 22 | 0.210 |
Why?
| | Animals, Congenic | 2 | 2017 | 9 | 0.200 |
Why?
| | Cerebellum | 5 | 2007 | 225 | 0.190 |
Why?
| | Receptors, GABA-A | 4 | 2018 | 138 | 0.180 |
Why?
| | Exome | 2 | 2014 | 232 | 0.180 |
Why?
| | Cues | 1 | 2004 | 326 | 0.170 |
Why?
| | Pro-Opiomelanocortin | 2 | 1998 | 20 | 0.170 |
Why?
| | Postural Balance | 2 | 2001 | 241 | 0.160 |
Why?
| | Prefrontal Cortex | 2 | 2011 | 338 | 0.160 |
Why?
| | Prealbumin | 2 | 2013 | 37 | 0.150 |
Why?
| | Association Learning | 1 | 2000 | 69 | 0.150 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1429 | 0.150 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.140 |
Why?
| | beta-Endorphin | 1 | 1998 | 4 | 0.140 |
Why?
| | Signal Transduction | 2 | 2011 | 5234 | 0.140 |
Why?
| | Proton Pump Inhibitors | 1 | 2018 | 101 | 0.130 |
Why?
| | Biomedical Research | 1 | 2004 | 724 | 0.130 |
Why?
| | Chromosomes, Mammalian | 2 | 2007 | 28 | 0.130 |
Why?
| | Environment | 1 | 1998 | 295 | 0.120 |
Why?
| | Sex Factors | 2 | 2016 | 2101 | 0.120 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 1996 | 59 | 0.120 |
Why?
| | Female | 18 | 2020 | 79080 | 0.120 |
Why?
| | Central Nervous System | 1 | 1998 | 278 | 0.120 |
Why?
| | Rotarod Performance Test | 2 | 2006 | 15 | 0.120 |
Why?
| | Animals, Inbred Strains | 1 | 2015 | 6 | 0.110 |
Why?
| | Models, Genetic | 2 | 2017 | 537 | 0.110 |
Why?
| | Lung Neoplasms | 5 | 2010 | 2674 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2016 | 3121 | 0.110 |
Why?
| | Hippocampus | 2 | 2018 | 986 | 0.110 |
Why?
| | Protein Kinase C | 2 | 2006 | 250 | 0.110 |
Why?
| | Mutation | 3 | 2013 | 4082 | 0.100 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 39 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2017 | 2228 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2006 | 751 | 0.100 |
Why?
| | Inositol Phosphates | 1 | 1993 | 21 | 0.100 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 2 | 2018 | 233 | 0.100 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2011 | 72 | 0.100 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 152 | 0.100 |
Why?
| | Phosphatidylinositols | 1 | 1993 | 59 | 0.100 |
Why?
| | Piperazines | 1 | 1996 | 367 | 0.100 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.100 |
Why?
| | Enkephalins | 1 | 2013 | 21 | 0.100 |
Why?
| | Genetic Association Studies | 1 | 2015 | 376 | 0.100 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 189 | 0.090 |
Why?
| | Sodium Chloride | 1 | 2013 | 138 | 0.090 |
Why?
| | Receptors, Neurotransmitter | 1 | 1992 | 20 | 0.090 |
Why?
| | Myosins | 1 | 2013 | 131 | 0.090 |
Why?
| | Mesencephalon | 3 | 2006 | 65 | 0.090 |
Why?
| | Corpus Striatum | 2 | 2006 | 181 | 0.090 |
Why?
| | Protein Precursors | 1 | 2013 | 127 | 0.090 |
Why?
| | Genomics | 1 | 2017 | 851 | 0.090 |
Why?
| | Butylated Hydroxytoluene | 2 | 2002 | 37 | 0.090 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 1 | 2011 | 20 | 0.090 |
Why?
| | Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2011 | 8 | 0.080 |
Why?
| | RNA, Messenger | 5 | 2018 | 2783 | 0.080 |
Why?
| | Synaptic Potentials | 1 | 2011 | 17 | 0.080 |
Why?
| | Nucleus Accumbens | 3 | 2006 | 135 | 0.080 |
Why?
| | Mice, Inbred A | 1 | 2010 | 47 | 0.080 |
Why?
| | Ataxia | 2 | 2009 | 69 | 0.080 |
Why?
| | Drug-Seeking Behavior | 1 | 2010 | 22 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1202 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 314 | 0.080 |
Why?
| | Long-Term Potentiation | 2 | 2011 | 206 | 0.080 |
Why?
| | Injections, Intraperitoneal | 2 | 2006 | 115 | 0.080 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 767 | 0.080 |
Why?
| | Mice, Inbred C3H | 1 | 2010 | 252 | 0.080 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 319 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 611 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1169 | 0.080 |
Why?
| | Genes, ras | 1 | 2010 | 70 | 0.080 |
Why?
| | Sleep Stages | 1 | 1990 | 76 | 0.080 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 66 | 0.070 |
Why?
| | Arousal | 1 | 1990 | 157 | 0.070 |
Why?
| | Time Factors | 3 | 2011 | 7079 | 0.070 |
Why?
| | Down-Regulation | 1 | 2011 | 612 | 0.070 |
Why?
| | Body Temperature Regulation | 1 | 1990 | 106 | 0.070 |
Why?
| | Software | 1 | 2014 | 673 | 0.070 |
Why?
| | Radioimmunoassay | 4 | 2001 | 162 | 0.070 |
Why?
| | Learning | 2 | 2011 | 446 | 0.070 |
Why?
| | Fibrosarcoma | 1 | 2008 | 22 | 0.070 |
Why?
| | Putamen | 2 | 2006 | 23 | 0.070 |
Why?
| | Time and Motion Studies | 2 | 1998 | 28 | 0.070 |
Why?
| | Alcoholic Intoxication | 2 | 2006 | 77 | 0.070 |
Why?
| | Neovascularization, Pathologic | 1 | 2009 | 285 | 0.060 |
Why?
| | Butyrates | 1 | 2008 | 65 | 0.060 |
Why?
| | Angiogenesis Inhibitors | 1 | 2009 | 238 | 0.060 |
Why?
| | Hypothermia | 2 | 2006 | 53 | 0.060 |
Why?
| | Neuronal Plasticity | 2 | 2001 | 311 | 0.060 |
Why?
| | Erythropoietin | 1 | 2008 | 100 | 0.060 |
Why?
| | Protein Engineering | 1 | 2008 | 122 | 0.060 |
Why?
| | Cocaine | 3 | 1993 | 162 | 0.060 |
Why?
| | Gene Frequency | 1 | 2007 | 495 | 0.060 |
Why?
| | Pneumonia | 2 | 2002 | 633 | 0.060 |
Why?
| | Reaction Time | 1 | 2007 | 434 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2006 | 266 | 0.050 |
Why?
| | Organ Specificity | 3 | 1997 | 306 | 0.050 |
Why?
| | Electroshock | 1 | 2004 | 146 | 0.050 |
Why?
| | Body Temperature | 1 | 2005 | 227 | 0.050 |
Why?
| | Analysis of Variance | 2 | 1998 | 1293 | 0.050 |
Why?
| | Age Factors | 1 | 2011 | 3321 | 0.050 |
Why?
| | Acoustic Stimulation | 1 | 2004 | 322 | 0.050 |
Why?
| | Memory | 2 | 2002 | 298 | 0.050 |
Why?
| | Gene Deletion | 1 | 2003 | 384 | 0.040 |
Why?
| | Pentobarbital | 1 | 2001 | 17 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2003 | 310 | 0.040 |
Why?
| | Haloperidol | 1 | 2001 | 27 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 2009 | 927 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1996 | 588 | 0.040 |
Why?
| | Humans | 9 | 2016 | 145625 | 0.040 |
Why?
| | RNA Editing | 1 | 2001 | 26 | 0.040 |
Why?
| | Mice, Congenic | 1 | 2000 | 23 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 2097 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1758 | 0.040 |
Why?
| | Neurons | 2 | 2007 | 1663 | 0.040 |
Why?
| | Antipsychotic Agents | 1 | 2001 | 178 | 0.040 |
Why?
| | Aging | 1 | 2010 | 1983 | 0.040 |
Why?
| | Kinetics | 2 | 1993 | 1553 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 70 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1223 | 0.030 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 19 | 0.030 |
Why?
| | Ribonucleases | 1 | 1998 | 49 | 0.030 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2591 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 365 | 0.030 |
Why?
| | Carrier Proteins | 2 | 1992 | 728 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2018 | 182 | 0.030 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2017 | 49 | 0.030 |
Why?
| | Gene Expression | 2 | 2018 | 1461 | 0.030 |
Why?
| | Ribosomal Proteins | 1 | 2017 | 93 | 0.030 |
Why?
| | Systems Biology | 1 | 2017 | 68 | 0.030 |
Why?
| | Naltrexone | 1 | 1998 | 114 | 0.030 |
Why?
| | Synapses | 1 | 2001 | 447 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2018 | 507 | 0.030 |
Why?
| | Seizures | 1 | 2001 | 489 | 0.030 |
Why?
| | Microinjections | 1 | 1996 | 92 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1996 | 185 | 0.030 |
Why?
| | Narcotic Antagonists | 1 | 1998 | 209 | 0.030 |
Why?
| | Carcinogens | 2 | 2010 | 111 | 0.030 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 199 | 0.030 |
Why?
| | Receptors, Drug | 2 | 1992 | 10 | 0.030 |
Why?
| | Regression Analysis | 1 | 1998 | 994 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1998 | 771 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 847 | 0.030 |
Why?
| | Emotions | 1 | 1999 | 555 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2014 | 28 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 973 | 0.030 |
Why?
| | Carbachol | 1 | 1993 | 17 | 0.030 |
Why?
| | Histamine H1 Antagonists | 1 | 1993 | 24 | 0.030 |
Why?
| | Inositol | 1 | 1993 | 25 | 0.030 |
Why?
| | Second Messenger Systems | 1 | 1993 | 31 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 3538 | 0.020 |
Why?
| | Hydrolysis | 1 | 1993 | 195 | 0.020 |
Why?
| | Membrane Lipids | 1 | 1993 | 81 | 0.020 |
Why?
| | Urethane | 2 | 2003 | 43 | 0.020 |
Why?
| | Calcium | 2 | 2001 | 1181 | 0.020 |
Why?
| | Phospholipids | 1 | 1993 | 215 | 0.020 |
Why?
| | Piperidines | 1 | 1993 | 223 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 693 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2007 | 2533 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 257 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 22451 | 0.020 |
Why?
| | Amnesia | 1 | 2011 | 47 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 1526 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2119 | 0.020 |
Why?
| | Depression, Chemical | 1 | 1990 | 16 | 0.020 |
Why?
| | Tissue Extracts | 1 | 1990 | 19 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2014 | 2835 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2009 | 120 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 294 | 0.020 |
Why?
| | Microvessels | 1 | 2009 | 98 | 0.020 |
Why?
| | Silymarin | 1 | 2009 | 147 | 0.020 |
Why?
| | Glycosylation | 1 | 2008 | 175 | 0.020 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2007 | 47 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2009 | 214 | 0.020 |
Why?
| | Electrophysiology | 1 | 2007 | 219 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 926 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2006 | 13 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 845 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1717 | 0.020 |
Why?
| | Potassium Channels, Tandem Pore Domain | 1 | 2006 | 12 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2006 | 51 | 0.010 |
Why?
| | Receptors, Steroid | 1 | 2006 | 41 | 0.010 |
Why?
| | Myelin Proteolipid Protein | 1 | 2006 | 61 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 561 | 0.010 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2006 | 76 | 0.010 |
Why?
| | DNA Primers | 1 | 2006 | 487 | 0.010 |
Why?
| | Synaptic Transmission | 1 | 2007 | 292 | 0.010 |
Why?
| | NF-kappa B | 1 | 2009 | 674 | 0.010 |
Why?
| | Neoplasm Proteins | 1 | 2008 | 443 | 0.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 210 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 787 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1709 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1361 | 0.010 |
Why?
| | Homozygote | 1 | 2003 | 196 | 0.010 |
Why?
| | Computer Simulation | 1 | 2008 | 1014 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2218 | 0.010 |
Why?
| | Discrimination Learning | 1 | 2002 | 53 | 0.010 |
Why?
| | Sex Distribution | 1 | 2003 | 379 | 0.010 |
Why?
| | Heterozygote | 1 | 2003 | 310 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 594 | 0.010 |
Why?
| | Reflex, Startle | 1 | 2002 | 74 | 0.010 |
Why?
| | Methylcholanthrene | 1 | 2002 | 21 | 0.010 |
Why?
| | Lod Score | 1 | 2002 | 62 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2003 | 339 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1429 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2009 | 2497 | 0.010 |
Why?
| | Perforant Pathway | 1 | 2001 | 3 | 0.010 |
Why?
| | Kainic Acid | 1 | 2001 | 33 | 0.010 |
Why?
| | Cytokines | 1 | 2009 | 2079 | 0.010 |
Why?
| | Dentate Gyrus | 1 | 2001 | 41 | 0.010 |
Why?
| | Macrophages | 1 | 2009 | 1530 | 0.010 |
Why?
| | Flunitrazepam | 1 | 2000 | 3 | 0.010 |
Why?
| | Tritium | 1 | 2000 | 64 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2001 | 290 | 0.010 |
Why?
| | Alleles | 1 | 2003 | 900 | 0.010 |
Why?
| | Apoptosis | 1 | 2009 | 2436 | 0.010 |
Why?
| | Anti-Anxiety Agents | 1 | 2000 | 46 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 269 | 0.010 |
Why?
| | Transgenes | 1 | 2000 | 178 | 0.010 |
Why?
| | RNA | 1 | 2006 | 925 | 0.010 |
Why?
| | Body Weight | 1 | 2003 | 964 | 0.010 |
Why?
| | Gene Dosage | 1 | 1999 | 146 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1041 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2006 | 1467 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3396 | 0.010 |
Why?
| | Transcription Factors | 1 | 2006 | 1728 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1997 | 94 | 0.010 |
Why?
| | Binding Sites | 1 | 2001 | 1306 | 0.010 |
Why?
| | Chromosomes | 1 | 1997 | 105 | 0.010 |
Why?
| | Genetic Linkage | 1 | 1997 | 269 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1999 | 1244 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2000 | 2131 | 0.010 |
Why?
| | Caudate Nucleus | 1 | 1993 | 23 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4112 | 0.010 |
Why?
| | Self Administration | 1 | 1993 | 121 | 0.010 |
Why?
| | Hypothalamus | 1 | 1993 | 161 | 0.010 |
Why?
| | Prosencephalon | 1 | 1992 | 52 | 0.010 |
Why?
| | Hypnosis | 1 | 1992 | 12 | 0.010 |
Why?
| | Pharmacogenetics | 1 | 1993 | 176 | 0.010 |
Why?
| | Stereotyped Behavior | 1 | 1991 | 22 | 0.010 |
Why?
| | Cell Membrane | 1 | 1992 | 701 | 0.000 |
Why?
|
|
Radcliffe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|